CIRG publications

• Journal articles
• Conference proceedings
• Presentations
• Preprints

Journal articles

• Walker J, Russell P, Kermack L, Van TT, Thieu Nga TV, Mylona E, Camara S, Kim YC, Shrestha S, Gehlhaar A , Scott JB et al (2025) Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study. PLOS Neglected Tropical Diseases, 19(10). View this article in WRRO
• Townsley H, Locke T, Laundy N, Keil C, Keeley AJ, Hamilton J, Pandor A, Darton T & de Silva TI (2025) A systematic review of asymptomatic colonisation with Group A Streptococcus in lower and middle income countries. Journal of Infection. View this article in WRRO
• Preston L, Thompson A, Baxter S, Chambers D, Collini P, Falzon L, Goodall J & Lee A (2025) A rapid review of the causes of diagnostic and treatment delays for tuberculosis in low burden countries. Journal of Public Health. View this article in WRRO
• Hodgson D, Hay J, Jarju S, Jobe D, Wenlock R, de Silva TI & Kucharski AJ (2025) serojump: a Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data. PLoS Computational Biology, 21(9). View this article in WRRO
• Abani O, Abbas A, Abbas F, Abbas K, Abbas M, Abbasi J, Abbasi S, Abbass H, Abbott A, Abdallah N , Abdelaziz A et al (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. View this article in WRRO
• Sanyang B, Dabrowska MB, Amenyogbe N, Camara B, Beloum N, Jammeh M, Bojang D, Goodall J, Mohammed N, Sesay AK , Roca A et al (2025) Effect of intrapartum azithromycin on early childhood gut mycobiota development: post hoc analysis of a double-blind randomized trial. Nature Communications, 16. View this article in WRRO
• Keeley AJ, Camara FE, Armitage EP, de Crombrugghe G, Sillah J, Fofana ML, Rollinson V, Senghore E, Jammeh M, Whitcombe AL , Bittaye A et al (2025) Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting. Nature Medicine, 31(10), 3360-3371. View this article in WRRO
• McLornan DP, Hazenberg MD, Ciceri F, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Chakraverty R, Booth C, Heemskerk MHM , Holler E et al (2025) Advancing the integration of ‘basic/fundamental’ and translational cellular and gene therapy science within the EBMT: Accelerating the pathway to progress. Bone Marrow Transplantation. View this article in WRRO
• Johnston PI, Chisala W, Hinchcliffe A, Mhango C, Jambo N, Cooper MR, Shahi F, Gordon MA & Darton TC (2025) HIV status and the risk of typhoid fever and iNTS: a systematic review and meta-analysis. Journal of Infection, 91(3). View this article in WRRO
• Symes R, Keddie SH, Walker J, McKeever T, Ahmad S, Arnold D, Evans CM, Pelosi E, Rahman NM, Sapey E , Zambon M et al (2025) Burden of respiratory syncytial virus infection in older adults hospitalised in England during 2023/24. Journal of Infection, 91(3), 106570-106570.
• Yengo CK, Torimiro J, Kowo M, Lebon PA, Tiedeu BA, Luma H, Njoya O, Rowland-Jones S & Yindom L-M (2025) Corrigendum to “Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon” [Heliyon Volume 6, Issue 10, October 2020, article e05232]. Heliyon, 11(13), e43443-e43443.
• Jeena L, Ferrand RA, Simms V, Kahari C, Bandason T, Rukuni R, Rehmand AM, Rowland-Jones S, Hsieh AYY & Gregson CL (2025) Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum. AIDS, 39(11), 1674-1675.
• Ashton PM, Mageiros L, Meiring JE, Chunga-Chirambo A, Khanam F, Dongol S, Banda H, Karkey A, Preciado-Llanes L, Thomaides-Brears H , Gibani M et al (2025) Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model. Microbiome, 13. View this article in WRRO
• Hao S, Tomic I, Lindsey BB, Jagne YJ, Hoschler K, Meijer A, Carreño Quiroz JM, Meade P, Sano K, Peno C , Costa-Martins AG et al (2025) Integrative mapping of pre-existing influenza immune landscapes predicts vaccine response. Journal of Clinical Investigation, 135(18). View this article in WRRO
• Rydlova A, Smith E, Stuart A, Shattock R, Brooks T, Darton TC, Piggin M, O'Hare R, McCartney A, Carey ME & Gibani MM (2025) Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025. Vaccine, 62. View this article in WRRO
• Armitage EP, Senghore E, Camara FE, Jarju S, Jagne S, Ceesay E, Darboe FF, de Crombrugghe G, Keeley AJ, Hall JN , Angyal A et al (2025) Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study. Journal of Infection, 91(2), 106546-106546.
• Carreño JM, Meade P, Sogodogo NF, Sano K, Tcheou J, Raskin A, Singh G, Fried M, Loganathan M, Francis B , Bielak D et al (2025) Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children. iScience, 28(7), 112893-112893.
• Payne RO, Edwards NJ, Themistocleous Y, Silk SE, Barrett JR, Rawlinson TA, Lim IW, Draper SJ & Minassian AM (2025) Diagnosis of Plasmodium falciparum malaria at very low parasitaemias using a commercially available LAMP assay and RDT. Transactions of The Royal Society of Tropical Medicine and Hygiene. View this article in WRRO
• de Crombrugghe G, Armitage EP, Keeley AJ, Senghore E, Camara F, Jammeh M, Bittaye A, Ceesay H, Ceesay I, Samateh B , Manneh M et al (2025) Household Molecular Epidemiology of Streptococcus pyogenes Carriage and Infection in The Gambia. The Journal of Infectious Diseases, 232(3), 550-559.
• Jagne YJ, Jobe D, Darboe A, Danso M, Barratt N, Gomez M, Wenlock R, Jarju S, Sylva EL, Touray AF , Toure F et al (2025) Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa. Communications Medicine, 5(1). View this article in WRRO
• Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N , Abdelaziz A et al (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. View this article in WRRO
• Atkinson B, Gould S, Nicholls I, Manzoor KN, Smith J, Hindle AJ, Tunbridge AJ, Cole J, Collini P, Alonso A , O’Hara G et al (2025) Air and surface sampling for clade Ib monkeypox virus in United Kingdom hospitals, 2024 to 2025. Eurosurveillance, 30(19). View this article in WRRO
• Chen J-L, Wang B, Lu Y, Antoun E, Bird O, Drennan PG, Yin Z, Liu G, Yao X, Pidoux M , Bates A et al (2025) T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination. Nature Communications, 16. View this article in WRRO
• Dyson ZA, Cerdeira L, Sharma V, Carey ME, Holt KE, Aanensen DM, Abbas AH, Fayad AA, Afolayan AO, Ahmed N , Ahmed I et al (2025) The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health. Genome Medicine, 17. View this article in WRRO
• Sharrack S, Cox M, Carter S, Cohen D, Collini P, Dunkley L, Umair H, Jade J, Maxwell JR, Raza M , Nadin T et al (2025) P002 Refining pre-immunosuppression protocols: a national survey and regional quality improvement project focusing on latent tuberculosis infection. Rheumatology, 64(Supplement_3).
• Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M, Busca A, Cordonnier C, Maertens J, Guisado MA , Akova M et al (2025) Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia, 39, 1547-1557. View this article in WRRO
• Olaru ID, Chingono RMS, Mhino F, Gregson C, Bottomley C, Bandason T, Mpandaguta CE, Madziva K, Ferrand RA, Vere M , Chonzi P et al (2025) Infectious diseases burden and antibiotic prescribing patterns among primary care patients in Harare, Zimbabwe – a cross-sectional analysis. PLOS Global Public Health, 5(4). View this article in WRRO
• Saso A, Kanteh E, Jeffries D, Okoye M, Mohammed N, Kumado M, Roetynck S, Jobe H, Faal A, Roberts E , Gageldonk P et al (2025) The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial. The Lancet Infectious Diseases, 25(8), 909-924.
• Mellors J, Dhaliwal R, Longet S, Tipton T, McInnes I, Siebert S, Kearns P, Rea D, Cook G, Willicombe M , Thomas D et al (2025) Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals. Nature Communications, 16(1). View this article in WRRO
• Locke TE, Keeley AJ, Laundy N, Keil C, Hamilton J, Pandor A, I de Silva T & Darton TC (2025) Prevalence and risk factors for Staphylococcus aureus colonisation among healthy individuals in low- and middle-income countries: a systematic review and meta-analysis. Journal of Infection, 90(4). View this article in WRRO
• Jeena L, Ferrand RA, Simms V, Kahari C, Bandason T, Rukuni R, Rehman AM, Rowland-Jones S, Hsieh AYY & Gregson CL (2025) Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe. AIDS, 39(6), 683-694. View this article in WRRO
• Payne R, Frejah I, Abbey E, Badcoe R, Delaney B & Mitchell C (2025) Transitioning between clinical and academic practice from the perspectives of clinical academic trainees, academic training programme directors and academic supervisors: a mixed methods study. BMC Medical Education, 25(1). View this article in WRRO
• Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N , Abdelaziz A et al (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. View this article in WRRO
• Paredes JL, Bemplidaki D, Dzavakwa NV, Chisenga M, Filteau S, Gregson CL, Kasonka L, Kranzer K, Banda-Mabuda H, Mujuru H , Redzo N et al (2025) P-563. Low level viremia is associated with viral non-suppression within 96 weeks among adolescents with perinatally acquired HIV: a prospective cohort study. Open Forum Infectious Diseases, 12(Supplement_1).
• Peno C, Jagne YJ, Clerc M, Balcazar Lopez C, Armitage EP, Sallah H, Drammeh S, Senghore E, Goderski G, van Tol S , Meijer A et al (2025) Interactions between live attenuated influenza vaccine and nasopharyngeal microbiota among children aged 24–59 months in The Gambia: a phase 4, open-label, randomised controlled trial. The Lancet Microbe, 6(3), 100971-100971.
• Massai L, Carducci M, Rovetini L, Paterson A, Whitcombe A, McGregor R, Lorenz N, Keeley AJ, de Silva TI, Bennett J , Berlanda Scorza F et al (2025) Characterization of an IL-8 cleavage inhibition assay to determine the functionality of anti-SpyCEP antibodies in human sera. Journal of Immunological Methods, 536, 113786-113786.
• Callaby H, Olver J, Emery K, Richards KS, Killip M, Groves N, Beadsworth MBJ, Price DA, Cooke GS, Collini P , Cole J et al (2025) Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients. The Lancet Infectious Diseases, 25(1), e4-e5.
• Hall JN, Armitage EP, Senghore E, Darboe S, Barry M, Camara J, Bah S, Keeley AJ, McCarthy JS, Smeesters P , Turner CE et al (2025) Molecular methods enhance the detection of pyoderma-related Streptococcus pyogenes and emm-type distribution in children. The Journal of Infectious Diseases, 231(1), e28-e37. View this article in WRRO
• Locke T, Siribaddana S, Jayaweera JAAS, Suligoy CM, de Silva TI, Corrigan RM & Darton TC (2024) A prospective cohort study to investigate the transmission and burden of Staphylococcus aureus in Sri Lanka. Microbial Genomics, 10(12). View this article in WRRO
• Colton H, Barratt N, Temperton N, Hornsby H, Angyal A, Grouneva I, Lindsey BB, Kearns P, Barnes E, Goodyear CS , Richter A et al (2024) Greater preservation of SARS‐CoV‐2 neutralising antibody responses following the ChAdOx1‐S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients. British Journal of Haematology, 205(6), 2206-2218. View this article in WRRO
• Saville TJ, Colton H, Jarju S, Armitage EP, Drammeh S, Tazzyman S, Jagne YJ, Sallah HJ, Senghore E, Evans CM , Darton TC et al (2024) Microfluidic qPCR for detection of 21 common respiratory viruses in children with influenza-like illness. Scientific Reports, 14(1). View this article in WRRO
• Saag M, Coutinho R, Rowland-Jones S, Lichterfeld M & Levy J (2024) John Phair. AIDS, 38(14), 1991-1991.
• Wiseman JP, Scarrott JM, Alves-Cruzeiro J, Saffari A, Böger C, Karyka E, Dawes E, Davies AK, Marchi PM, Graves E , Fernandes F et al (2024) Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. EMBO Molecular Medicine, 16(11), 2882-2917. View this article in WRRO
• Leavy OC, Russell RJ, Harrison EM, Lone NI, Kerr S, Docherty AB, Sheikh A, Richardson M, Elneima O, Greening NJ , Harris VC et al (2024) 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study. ERJ Open Research, 10(5). View this article in WRRO
• Dzavakwa NV, Simms V, Gregson CL, Chisenga M, Filteau S, Kasonka L, Kranzer K, Banda-Mabuda H, Mujuru H, Redzo N , Mukwasi-Kahari C et al (2024) Association between vitamin D insufficiency and impaired bone density among adolescents with perinatally acquired HIV infection. Open Forum Infectious Diseases, 11(9). View this article in WRRO
• Booth JS, Rapaka RR, McArthur MA, Fresnay S, Darton TC, Blohmke CJ, Jones C, Waddington CS, Levine MM, Pollard AJ & Sztein MB (2024) Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans. Frontiers in Immunology, 15. View this article in WRRO
• Toapanta FR, Hu J, Shirey KA, Bernal PJ, Levine MM, Darton TC, Waddington CS, Pollard AJ & Sztein MB (2024) Changes in monocyte subsets in volunteers who received an oral wild-type Salmonella Typhi challenge and reached typhoid diagnosis criteria. Frontiers in Immunology, 15. View this article in WRRO
• Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Donà D, Burzo S, Huttner BD, Chaillon A, Gebreselassie N, Wi T , Hasso-Agopsowicz M et al (2024) WHO global research priorities for antimicrobial resistance in human health. The Lancet Microbe, 5(11). View this article in WRRO
• Hall JN, Bah SY, Khalid H, Brailey A, Coleman S, Kirk T, Hussain N, Tovey M, Chaudhuri RR, Davies S , Tilley L et al (2024) Molecular characterization of Streptococcus pyogenes (StrepA) non-invasive isolates during the 2022–2023 UK upsurge. Microbial Genomics, 10(8). View this article in WRRO
• Galgut O, Ashford F, Deeks A, Ghataure A, Islam M, Sambhi T, Ker YW, Duncan CJA, de Silva TI, Hopkins S , Hall V et al (2024) COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review. Vaccine: X, 20, 100546-100546.
• Sanyang B, de Silva TI, Camara B, Beloum N, Kanteh A, Manneh J, de Steenhuijsen Piters WAA, Bogaert D, Sesay AK & Roca A (2024) Effect of intrapartum azithromycin on gut microbiota development in early childhood: A post hoc analysis of a double-blind randomized trial. iScience, 27(9), 110626-110626.
• Taquet M, Skorniewska Z, De Deyn T, Hampshire A, Trender WR, Hellyer PJ, Chalmers JD, Ho L-P, Horsley A, Marks M , Poinasamy K et al (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11(9), 696-708.
• Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N , Rowland-Jones S et al (2024) Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial. Trials, 25. View this article in WRRO
• Elneima O, Hurst JR, Echevarria C, Quint JK, Walker S, Siddiqui S, Novotny P, Pfeffer PE, Brown JS, Shankar-Hari M , McAuley HJC et al (2024) Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study – PHOSP-COVID. ERJ Open Research, 10(4). View this article in WRRO
• Dyson ZA, Ashton PM, Khanam F, Chunga Chirambo A, Shakya M, Meiring JE, Tonks S, Karkey A, Msefula C, Clemens JD , Dunstan SJ et al (2024) Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study. The Lancet Microbe, 5(8). View this article in WRRO
• Gea-Mallorquí E & Rowland-Jones S (2024) Rethinking pDCs: a questionable ally in immunity?. Nature Reviews Immunology, 24(8), 542-542.
• Mushunje PK, Dube FS, Olwagen C, Madhi S, Odland J, Ferrand RA, Nicol MP, Abotsi RE, Bandason T, Dauya E , Madanhire T et al (2024) Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: a case–control study. BMC Infectious Diseases, 24(1). View this article in WRRO
• Cooper R, Greig J, Piercy H & Collini P (2024) Investigating the pregnancy and post-partum health experiences of women living with HIV. Maternal and Child Health Journal, 28(8), 1330-1337. View this article in WRRO
• Nazziwa J, Andrews SM, Hou MM, Bruhn CAW, Garcia-Knight MA, Slyker J, Hill S, Lohman Payne B, Moringas D, Lemey P , John-Stewart G et al (2024) Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants. Journal of Virology, 98(7).
• Brudenell EL, Pohare MB, Zafred D, Phipps J, Hornsby HR, Darby JF, Dai J, Liggett E, Cain KM, Barran PE , de Silva TI et al (2024) Efficient overexpression and purification of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteins in Escherichia coli. Biochemical Journal, 481(11), 669-682. View this article in WRRO
• Dockrell DH, Breen R, Collini P, Lipman MCI & Miller RF (2024) British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024. HIV Medicine, 25(S2), 3-37.
• Rowland-Jones S & Gea-Mallorquí E (2024) Closing the equity gap in the treatment of HIV-2 infection. The Lancet HIV, 11(6), e347-e349.
• Armitage EP, de Crombrugghe G, Keeley AJ, Senghore E, Camara FE, Jammeh M, Bittaye A, Ceesay H, Ceesay I, Samateh B , Manneh M et al (2024) Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study. The Lancet Microbe, 5(7), 679-688.
• Liu C, Zhou D, Dijokaite-Guraliuc A, Supasa P, Duyvesteyn HME, Ginn HM, Selvaraj M, Mentzer AJ, Das R, de Silva TI , Ritter TG et al (2024) A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity. Cell Reports Medicine, 5(5), 101553-101553.
• Goodyear CS, Patel A, Barnes E, Willicombe M, Siebert S, de Silva TI, Snowden JA, Lim SH, Bowden SJ, Billingham L , Richter A et al (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6(6), e339-e351. View this article in WRRO
• Jarju S, Wenlock RD, Danso M, Jobe D, Jagne YJ, Darboe A, Kumado M, Jallow Y, Touray M, Ceesay EA , Gaye H et al (2024) High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia. Nature Communications, 15(1). View this article in WRRO
• Ali M, Longet S, Neale I, Rongkard P, Chowdhury FUH, Hill J, Brown A, Laidlaw S, Tipton T, Hoque A , Hassan N et al (2024) Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery. Clinical and Experimental Immunology, 218(1), 78-92. View this article in WRRO
• Liew F, Efstathiou C, Fontanella S, Richardson M, Saunders R, Swieboda D, Sidhu JK, Ascough S, Moore SC, Mohamed N , Nunag J et al (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25(4), 607-621. View this article in WRRO
• Torimiro JNE, Duri K, Goumkwa NM, Atah SM, Ndzie Ondigui J-L, Lobe C, Bouyou M, Ndeboko B, Mahamat Moussa A, Police C , Awoumou P et al (2024) Toward the elimination of hepatitis B: networking to promote the prevention of vertical transmission of hepatitis B virus through population-based interventions and multidisciplinary groups in Africa. Frontiers in Public Health, 12. View this article in WRRO
• Suau Sans M, Manneh M, Ceesay I, Bittaye A, de Crombrugghe G, Keeley AJ, de Silva TI, Palmer J, Armitage EP & Marks M (2024) Health-seeking behaviour and beliefs around sore throat in The Gambia: A qualitative study. PLOS Global Public Health, 4(3). View this article in WRRO
• Lindquist L, Kilembe W, Karita E, Price MA, Kamali A, Kaleebu P, Tang J, Allen S, Hunter E, Gilmour J , Rowland-Jones SL et al (2024) HLA-A*23 Is associated with lower odds of acute retroviral syndrome in human immunodeficiency virus type 1 infection: a multicenter sub-Saharan African study. Open Forum Infectious Diseases, 11(4). View this article in WRRO
• Moreno-Cubero E, Alrubayyi A, Balint S, Ogbe A, Gill US, Matthews R, Kinloch S, Burns F, Rowland-Jones SL, Borrow P , Schurich A et al (2024) IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection. JCI Insight, 9(4). View this article in WRRO
• Ashton PM, Chunga Chirambo A, Meiring JE, Patel PD, Mbewe M, Silungwe N, Chizani K, Banda H, Heyderman RS, Dyson ZA , MacPherson P et al (2024) Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study. The Lancet Microbe, 5(3), e226-e234. View this article in WRRO
• Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O , Coles AJ et al (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14(2). View this article in WRRO
• Sandercock P, Darbyshire J, DeMets D, Fowler R, Lalloo D, Munavvar M, Warris A, Wittes J, Cradduck-Bamford A, Barton J , Basoglu A et al (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. View this article in WRRO
• Harrison T, Clark J & Darton TC (2024) Less is more: uptake of recommended vaccines in a UK travel clinic. Journal of Infection, 88(3). View this article in WRRO
• Faust SN, Haynes R, Jones CE, Staplin N, Whittaker E, Jaki T, Juszczak E, Spata E, Wan M, Bamford A , Dimitri P et al (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8(3), 190-200. View this article in WRRO
• Carducci M, Whitcombe A, Rovetini L, Massai L, Keeley AJ, de Silva TI, Bennett J, Berlanda Scorza F, Iturriza M, Moreland NJ , Moriel DG et al (2024) Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera. Journal of Immunological Methods, 526, 113618-113618.
• Sidhu JK, Siggins MK, Liew F, Russell CD, Uruchurtu ASS, Davis C, Turtle L, Moore SC, Hardwick HE, Oosthuyzen W , Thomson EC et al (2024) Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19. The Journal of Infectious Diseases, 230(1), e17-e29. View this article in WRRO
• Michael BD, Dunai C, Needham EJ, Tharmaratnam K, Williams R, Huang Y, Boardman SA, Clark JJ, Sharma P, Subramaniam K , Wood GK et al (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14(1). View this article in WRRO
• Gupta V, Kariotis S, Rajab MD, Errington N, Alhathli E, Jammeh E, Brook M, Meardon N, Collini P, Cole J , Wild JM et al (2023) Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices. npj Digital Medicine, 6. View this article in WRRO
• Shahi F, Collini P & Darton T (2023) 53 TRANSLATE TB: Transcriptional signatures for latent TB, Sheffield, UK. Clinical Infection in Practice, 20(Supplement 1). View this article in WRRO
• Hall J, Angyal A, Armitage E, Senghore E, Darboe S, Barry M, Camara J, Bah S, Keeley A, McCarthy J , Turner C et al (2023) 44 Quantitative PCR demonstrates the underestimated burden of Streptococcus pyogenes as a cause of paediatric pyoderma in The Gambia. Clinical Infection in Practice, 20(Supplement 1). View this article in WRRO
• (2023) Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study. International journal of epidemiology, 53(1).
• Hardman SJ, Shackley FM, Ugonna K, Darton TC, Rigby AS, Bogaert D, Binkowska JM & Condliffe AM (2023) Seasonal azithromycin use in paediatric protracted bacterial bronchitis does not promote antimicrobial resistance but does modulate the nasopharyngeal microbiome. International Journal of Molecular Sciences, 24(22). View this article in WRRO
• Alrubayyi A, Touizer E, Hameiri-Bowen D, Charlton B, Gea-Mallorquí E, Hussain N, da Costa KAS, Ford R, Rees-Spear C, Fox TA , Williams I et al (2023) Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. Scientific Reports, 13(1). View this article in WRRO
• Gea-Mallorquí E & Rowland-Jones S (2023) DC-targeting lentivectors for cancer immunotherapy. Immunotherapy Advances, 3(1).
• Barnes MVC, Mandla A, Smith E, Maskuniitty M, Openshaw PJM, Abo Y-N, Ascough S, Ashwin H, Avirutnan P, Catchpole AP , Chi PC et al (2023) Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022. Immunotherapy Advances, 3(1). View this article in WRRO
• Armitage EP, Keeley AJ, de Crombrugghe G, Senghore E, Camara FE, Jammeh M, Bittaye A, Ceesay H, Ceesay I, Samateh B , Manneh M et al (2023) Streptococcus pyogenes carriage acquisition, persistence and transmission dynamics within households in The Gambia (SpyCATS): protocol for a longitudinal household cohort study. Wellcome Open Research, 8. View this article in WRRO
• Keeley AJ, Camara FE, Armitage EP, de Crombrugghe G, Sillah J, Fofana ML, Rollinson V, Senghore E, Jammeh M, Whitcombe AL , Bittaye A et al () Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting. Nature Medicine.
• Nazziwa J, Freyhult E, Hong M-G, Johansson E, Årman F, Hare J, Gounder K, Rezeli M, Mohanty T, Kjellström S , Kamali A et al () Dynamics of the blood plasma proteome during hyperacute HIV-1 infection. Nature Communications, 15(1).
• Michael BD, Dunai C, Needham EJ, Tharmaratnam K, Williams R, Huang Y, Boardman SA, Clark JJ, Sharma P, Subramaniam K , Wood GK et al () Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 15(1).

Conference proceedings

• Saunders L, Collier G, Norquay G, Smith L, Hughes P, Strikland S, Gustafsson L, Newman T, Plowright M, Watson J , Gabriel Z et al () 129Xe red blood cell chemical shift and T2* in patients hospitalised due to COVID-19 with and without residual lung abnormalities seen on CT. ISMRM Annual Meeting, 10 May 2025 - 15 May 2025.

Presentations

• Lim JJ, Roberts C, Jauhar Ali SN, Collini P, Burney A & Hughes D Exploring students’ and examiners’ perceptions of the sequential OSCE: A qualitative study. Basel, Switzerland. View this article in WRRO

Preprints

• Alrubayyi A, Hassan AS, Hare J, Hsieh A, Gilmour J, Price MA, Kilembe W, Karita E, Ruzagira E, Esbjörnsson J , Sanders EJ et al (2025) An early functional adaptive NK cell signature drives optimal CD8⁺T-cell activation and predicts sustained HIV-1 viral control, Cold Spring Harbor Laboratory.
• Walker J, Russell P, Kermack L, Van TT, Nga TVT, Mylona E, Camara S, Kim YC, Shrestha S, Gehlhaar A , Scott JB et al (2025) Leveraging paired serology to estimate the incidence of typhoidalSalmonellainfection in the STRATAA study, Cold Spring Harbor Laboratory.
• Hsieh AYY, Hassan AS, Nazziwa J, Karlson S, Lindquist L, Hare J, Kamali A, Karita E, Kilembe W, Price MA , Björkman P et al (2025) Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rate, Cold Spring Harbor Laboratory.
• Hodgson D, Hay J, Jarju S, Jobe D, Wenlock R, de Silva TI & Kucharski AJ (2025) serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data, Cold Spring Harbor Laboratory.
• Keeley AJ, Camara FE, Armitage E, de Crombrugghe G, Sillah J, Fofana ML, Rollinson V, Senghore E, Jammeh M, Whitcombe AL , Bittaye A et al (2025) Early life serological profiles and the development of natural protective humoral immunity toStreptococcus pyogenesin a high burden setting, Cold Spring Harbor Laboratory.
• Hao S, Tomic I, Lindsey BB, Jagne YJ, Hoschler K, Meijer A, Quiroz JMC, Meade P, Sano K, Peno C , Costa-Martins AG et al (2025) Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response Prediction, Cold Spring Harbor Laboratory.
• Srour S, ElGhazaly M, O’Connor D, Gibani MM, Darton TC, Pollard AJ, Collins MO & Humphreys D (2024) Typhoid toxin of Salmonella Typhi elicits host antimicrobial response during acute typhoid fever, Cold Spring Harbor Laboratory.
• JAGNE YJ, Jobe D, Darboe A, Danso M, Barratt N, Gomez M, Wenlock R, Jarju S, Sylva E, Touray AF , Toure F et al (2024) Compartmentalised mucosal and blood immunity to SARS-CoV-2 associated with high seroprevalence before Delta wave in Africa, Springer Science and Business Media LLC.
• Ashton PM, Mageiros L, Meiring JE, Chirambo AC, Khanam F, Dongol S, Banda H, Karkey A, Llanes LP, Thomaides-Brears H , Gibani M et al (2024) Interplay Between the Gut Microbiome and Typhoid Fever: Insights from Endemic Countries and a Controlled Human Infection Model, Cold Spring Harbor Laboratory.
• Hall JN, Bah SY, Khalid H, Brailey A, Coleman S, Kirk T, Hussain N, Tovey M, Chaudhuri RR, Davies S , Tilley L et al (2024) Molecular characterisation ofStreptococcus pyogenes(StrepA) non-invasive isolates during the 2022-23 UK upsurge, Cold Spring Harbor Laboratory.
• Nazziwa J, Freyhult E, Hong M-G, Johansson E, Årman F, Hare J, Gounder K, Rezeli M, Mohanty T, Kjellström S , Kamali A et al (2024) Dynamics of the blood plasma proteome during hyperacute HIV-1 infection, Cold Spring Harbor Laboratory.
• Hall JN, Armitage EP, Senghore E, Darboe S, Barry M, Camara J, Bah S, Keeley AJ, McCarthy JS, Smeesters P , Turner CE et al (2024) Molecular methods enhance the detection of pyoderma-related Streptococcus pyogenes and emm-type distribution in children, Cold Spring Harbor Laboratory.
• Brudenell EL, Pohare MB, Zafred D, Phipps J, Hornsby HR, Darby J, Dai J, Liggett E, Cain K, Barran PE , de Silva TI et al (2024) Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins inEscherichia coli, Cold Spring Harbor Laboratory.
• Openshaw P, Liew F, Efstathiou C, Fontanella S, Richardson M, Saunders R, Swieboda D, Sidhu J, Ascough S, Moore S , Mohamed N et al (2023) Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease after COVID-19 hospitalisation, Springer Science and Business Media LLC.